Hualan Biological Engineering
002007.SZ
#3438
Rank
$3.99 B
Marketcap
$2.19
Share price
-0.06%
Change (1 day)
-5.39%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): $0.19 Billion USD

According to Hualan Biological Engineering's latest financial reports the company's current earnings are $0.63 Billion USD. In 2024 the company made an earning of $0.18 Billion USD a decrease over its 2023 earnings that were of $0.29 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.19 B5.81%
2024 $0.18 B-36.03%
2023 $0.29 B39.14%
2022 $0.21 B-19.27%
2021 $0.26 B-17.84%
2020 $0.31 B37.54%
2019 $0.23 B11.56%
2018 $0.20 B50.74%
2017 $0.13 B1.03%
2016 $0.13 B23.54%
2015 $0.11 B8.4%
2014 $0.10 B10.91%
2013 $91.58 M54.55%
2012 $59.25 M-17.1%
2011 $71.47 M-41.28%
2010 $0.12 B6.13%
2009 $0.11 B261.35%
2008 $31.73 M85.72%
2007 $17.08 M49.33%
2006 $11.44 M56.91%
2005 $7.29 M34.29%
2004 $5.43 M